1.60
price up icon5.26%   0.08
pre-market  시장 영업 전:  1.60  
loading
전일 마감가:
$1.52
열려 있는:
$1.49
하루 거래량:
311.07K
Relative Volume:
1.09
시가총액:
$56.84M
수익:
-
순이익/손실:
$-31.39M
주가수익비율:
-1.9048
EPS:
-0.84
순현금흐름:
$-18.45M
1주 성능:
+0.00%
1개월 성능:
+50.94%
6개월 성능:
-14.89%
1년 성능:
+116.95%
1일 변동 폭
Value
$1.48
$1.6669
1주일 범위
Value
$1.43
$1.68
52주 변동 폭
Value
$0.5116
$2.45

Quince Therapeutics Inc Stock (QNCX) Company Profile

Name
명칭
Quince Therapeutics Inc
Name
전화
415-910-5717
Name
주소
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Name
직원
36
Name
트위터
Name
다음 수익 날짜
2025-03-24
Name
최신 SEC 제출 서류
Name
QNCX's Discussions on Twitter

QNCX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
QNCX
Quince Therapeutics Inc
1.60 56.84M 0 -31.39M -18.45M -0.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-24 개시 Oppenheimer Outperform

Quince Therapeutics Inc 주식(QNCX)의 최신 뉴스

pulisher
Jun 19, 2025

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities - BioSpace

Jun 19, 2025
pulisher
Jun 18, 2025

Quince Therapeutics announces closing of up to $22 million private placement of securities - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities | QNCX Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 16, 2025

June 2025's Promising Penny Stocks For Savvy Investors - simplywall.st

Jun 16, 2025
pulisher
Jun 15, 2025

D. Boral Capital Reaffirms Buy Rating for Quince Therapeutics (NASDAQ:QNCX) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Takes $57,000 Position in Quince Therapeutics, Inc. (NASDAQ:QNCX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Quince Therapeutics (QNCX) Analyst Rating Update: Buy Rating Mai - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Quince Therapeutics Raises $11.5M in Private Placement - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Quince Therapeutics Announces Pricing of Up to $22 Million Priva - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities - BioSpace

Jun 13, 2025
pulisher
Jun 13, 2025

Quince Therapeutics (QNCX) Secures $11.5 Million Through New Sec - GuruFocus

Jun 13, 2025
pulisher
Jun 12, 2025

Quince Therapeutics (QNCX) Secures $11.5M Through Private Placem - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics (QNCX) Secures $11.5 Million Through New Securities Agreement | QNCX Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics Prices $22 Million Private Placement of Shares, Warrants - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities | QNCX Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics Announces Pricing Of Up To $22 Mln Private Placement Of Securities - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Quince Therapeutics stock soars after announcing $11.5 million private placement - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 08, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Quince Therapeutics (QNCX) and Moderna (MRNA) - The Globe and Mail

Jun 08, 2025
pulisher
Jun 05, 2025

Quince Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Quince Therapeutics’ (QNCX) “Buy” Rating Reaffirmed at D. Boral Capital - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Transcript : Quince Therapeutics, Inc.Shareholder/Analyst Call - marketscreener.com

Jun 04, 2025
pulisher
Jun 04, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Shares Acquired by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Quince Therapeutics (QNCX) Stock Rating and Price Target Update - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia - BioSpace

Jun 04, 2025
pulisher
Jun 03, 2025

Quince Therapeutics Says Enrollment for Phase 3 Clinical Trial in Ataxia-Telangiectasia Exceeds 75% - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Quince Therapeutics (QNCX) Phase 3 Trial Achieves Major Progress - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NE - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Quince Therapeutics (QNCX) Phase 3 Trial Achieves Major Progress in Enrollment | QNCX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Short Interest Down 42.9% in May - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

FY2025 Earnings Forecast for TSE:WEE Issued By Roth Capital - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Given Consensus Rating of “Buy” by Brokerages - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

May 30, 2025
pulisher
May 30, 2025

HC Wainwright Has Positive Estimate for ORKA Q2 Earnings - Defense World

May 30, 2025
pulisher
May 30, 2025

Q2 EPS Estimate for Century Therapeutics Raised by Analyst - Defense World

May 30, 2025
pulisher
May 21, 2025

Rani Therapeutics (NASDAQ:RANI) Stock Price Up 7% – Here’s What Happened - Defense World

May 21, 2025
pulisher
May 17, 2025

Finch Therapeutics Group (NASDAQ:FNCH) and Quince Therapeutics (NASDAQ:QNCX) Head to Head Comparison - Defense World

May 17, 2025
pulisher
May 17, 2025

Brookline Capital Management Forecasts QNCX Q2 Earnings - Defense World

May 17, 2025
pulisher
May 16, 2025

Quince Therapeutics secures USPTO nod for A-T treatment patent - MSN

May 16, 2025
pulisher
May 15, 2025

Quince Therapeutics: Data In Ataxia-Telangiectasia Scheduled For Early 2026 (NASDAQ:QNCX) - Seeking Alpha

May 15, 2025
pulisher
May 15, 2025

Quince Therapeutics Reports Q1 2025 Results and Strategic Updates - TipRanks

May 15, 2025
pulisher
May 13, 2025

Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results - BioSpace

May 13, 2025
pulisher
May 13, 2025

Quince Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Quince Therapeutics, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results | QNCX Stock News - GuruFocus

May 13, 2025
pulisher
May 12, 2025

QNCXQuince Latest Stock News & Market Updates - Stock Titan

May 12, 2025
pulisher
May 10, 2025

Quince Therapeutics (QNCX) Expected to Announce Earnings on Monday - Defense World

May 10, 2025
pulisher
May 07, 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX) Receives Average Recommendation of “Buy” from Analysts - Defense World

May 07, 2025
pulisher
May 05, 2025

Why Faraday Future Intelligent Electric Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Benzinga

May 05, 2025
pulisher
May 04, 2025

Quince Therapeutics (QNCX) CEO to Present at Life Sciences Confe - GuruFocus

May 04, 2025
pulisher
May 04, 2025

Quince Therapeutics (QNCX) CEO to Present at Life Sciences Conference - GuruFocus

May 04, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Has $703,000 Position in Quince Therapeutics, Inc. (NASDAQ:QNCX) - Defense World

May 02, 2025

Quince Therapeutics Inc (QNCX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Quince Therapeutics Inc 주식 (QNCX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Thye Dirk
CEO AND CHIEF MEDICAL OFFICER
Aug 29 '24
Buy
0.69
77,500
53,475
766,941
Ryan Charles S.
PRESIDENT
Aug 20 '24
Buy
0.65
48,387
31,452
122,461
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Aug 21 '24
Buy
0.63
30,845
19,337
296,540
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Aug 20 '24
Buy
0.60
5,924
3,579
265,695
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Aug 19 '24
Buy
0.58
2,155
1,250
259,771
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):